When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing outcomes with revascularization and stents in acute myocardial infarction) and CADILLAC (Controlled abciximab and device investigation to lower late angioplasty complications) trials

Journal of the American College of Cardiology

Volumn 56, Issue 5, 2010, Pages 407-413

  Brodie, Bruce R ^a   Gersh, Bernard J ^b   Stuckey, Thomas ^a   Witzenbichler, Bernhard ^c   Guagliumi, Giulio ^d   Peruga, Jan Z ^e   Dudek, Dariusz ^f   Grines, Cindy L ^g   Cox, David ^h   Parise, Helen ⁱ   Prasad, Abhiram ^b   Lansky, Alexandra J ⁱ   Mehran, Roxana ⁱ   Stone, Gregg W ⁱ  

^a LeBauer Cardiovascular Research Foundation   (United States)

^b MAYO CLINIC   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d OSPEDALI RIUNITI   (Italy)

^e Department of Radiology   (Poland)

^f JAGIELLONIAN UNIVERSITY   (Poland)

^g WILLIAM BEAUMONT HOSPITAL   (United States)

^h LEHIGH VALLEY HOSPITAL   (United States)

ⁱ Department of Medicine   (United States)

Author keywords

door to balloon time; myocardial infarction; primary percutaneous coronary intervention

Indexed keywords

ANTICOAGULANT AGENT; HIRULOG; ABCIXIMAB; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ANGIOPLASTY; ANTICOAGULANT THERAPY; ARTICLE; CARDIAC PATIENT; DOOR TO BALLOON TIME; DRUG ELUTING STENT; FEMALE; HEART ASSIST DEVICE; HIGH RISK PATIENT; HUMAN; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REPERFUSION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TIME; CARDIOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; CARDIOLOGY; FEMALE; HEART-ASSIST DEVICES; HOSPITALIZATION; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955283384     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.04.020     Document Type: Article

References (11)

1. C.P. Cannon, C.M. Gibson, and C.T. Lambrew Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction JAMA 283 2000 2941 2947
2. B.R. Brodie, C. Hansen, and T.D. Stuckey Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms J Am Coll Cardiol 47 2006 289 295
3. R.L. McNamara, Y. Wang, and J. Herrin Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol 47 2006 2180 2186
4. G.W. Stone, C.L. Grines, and D.A. Cox Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
5. G.W. Stone, B. Witzenbichler, and G. Guagliumi Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
6. D.A. Morrow, E.M. Antman, and A. Charlesworth TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation An intravenous nPA for treatment of infarcting myocardium early II Trial substudy Circulation 102 2000 2031 2037
7. B.J. Gersh, G.W. Stone, H.D. White, and D.R. Holmes Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction Is the slope of the curve the shape of the future? JAMA 293 2005 979 986
8. D.S. Pinto, A.J. Kirtane, and B.K. Nallamothu Hospital delays in reperfusion for ST-elevation myocardial infarction Implications when selecting a reperfusion strategy Circulation 114 2006 2019 2025
9. ASSENT-4 PCI Investigators Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI) randomized trial Lancet 367 2006 569 578
10. S.G. Ellis, M. Tendera, M.A. de Belder FINESSE Investigators Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2008 2205 2217
11. H.C. Herrmann, J. Lu, B.R. Brodie FINESSE Investigators Benefit of facilitated PCI in high risk ST-elevation myocardial infarction patients presenting to non-PCI hospitals J Am Coll Cardiol Intv 2 2009 917 924